Tammenoms Bakker Juliet
SEC CIK 1431159 · EDGAR
BoughtSold
Most active insiders at RXST, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Wilterding Mark | CFO | — | $54.0K |
| 2 | Kurtz Ronald M MD | Chief Medical Off | — | $35.5K |
| 3 | Goldshleger Ilya | See remarks | — | $14.2K |
| 4 | Weinberg Eric | See remarks | — | $14.2K |
| 5 | Gaines Scott | Chief Customer Off | — | — |
| 6 | Fountain Tamara | Dir | — | — |
| 7 | Corley Jesse Anderson | Dir | — | — |
| 8 | Warner Robert Keith | Dir | — | — |
| 9 | Maniar Shweta | Dir | — | — |
| 10 | Andrews Julie | Dir | — | — |
| 11 | Tammenoms Bakker Juliet | Dir | — | — |
Transactions 33
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-18 16:06 | 2026-06-17 | RXST | RxSight, Inc. | Tammenoms Bakker Juliet | Dir | A - Grant | — | +37.0K | 85.2K | +77% | — | |
| 2026-06-04 17:40 | 2026-06-02 | CBLL | Ceribell, Inc. | Tammenoms Bakker Juliet | Dir | A - Grant | $0.00 | +7,838 | 23.3K | +51% | $0 | |
| 2025-06-17 | 2025-06-10 | CBLL | Ceribell, Inc. | Tammenoms Bakker Juliet | Dir | A - Grant | $0.00 | +8,828 | 15.4K | +133% | $0 | |
| 2025-06-04 | 2025-06-03 | RXST | RxSight, Inc. | Tammenoms Bakker Juliet | Dir | A - Grant | — | +10.8K | 48.1K | +29% | — | |
| DI | 2024-10-16 | 2024-10-15 | CBLL | Ceribell, Inc. | Tammenoms Bakker Juliet | Dir | C - Cnv Deriv | — | +2.14M | 2.24M | +2,201% | — |
| DI | 2024-10-16 | 2024-10-15 | CBLL | Ceribell, Inc. | Tammenoms Bakker Juliet | Dir | P - Purchase | $17.00 | +237.2K | 2.48M | +11% | +$4.03M |
| D | 2024-10-16 | 2024-10-11 | CBLL | Ceribell, Inc. | Tammenoms Bakker Juliet | Dir | A - Grant | $0.00 | +6,618 | 6,618 | New | $0 |
| 2024-06-10 | 2024-06-06 | RXST | RxSight, Inc. | Tammenoms Bakker Juliet | Dir | A - Grant | — | +2,554 | 37.4K | +7% | — | |
| 2024-05-21 | 2024-05-17 | RXST | RxSight, Inc. | Tammenoms Bakker Juliet | Dir | P - Purchase | $61.09 | +5,000 | 34.8K | +17% | +$305.4K | |
| M | 2024-02-15 | 2024-02-12+ | RXST | RxSight, Inc. | Tammenoms Bakker Juliet | Dir | P - Purchase | $50.84 | +8,000 | 25.8K | +45% | +$406.7K |
| 2023-11-30 | 2023-11-30 | RXST | RxSight, Inc. | Tammenoms Bakker Juliet | Dir | J - Other | $0.00 | +1,617 | 21.8K | +8% | $0 | |
| MI | 2023-11-30 | 2023-11-30 | RXST | RxSight, Inc. | Tammenoms Bakker Juliet | Dir | J - Other | $0.00 | -444.7K | 1,548 | -100% | $0 |
| MI | 2023-11-30 | 2023-11-28+ | RXST | RxSight, Inc. | Tammenoms Bakker Juliet | Dir | S - Sale | $29.73 | -494.3K | 349.2K | -59% | -$14.69M |
| MI | 2023-11-16 | 2023-11-14+ | RXST | RxSight, Inc. | Tammenoms Bakker Juliet | Dir | S - Sale | $27.19 | -500.0K | 494.3K | -50% | -$13.59M |
| M | 2023-09-11 | 2023-09-07+ | RXST | RxSight, Inc. | Tammenoms Bakker Juliet | Dir | S - Sale | $30.14 | -33.0K | 20.2K | -62% | -$993.0K |
| 2023-08-28 | 2023-08-25 | RXST | RxSight, Inc. | Tammenoms Bakker Juliet | Dir | S - Sale | $29.25 | -16.2K | 53.2K | -23% | -$474.1K | |
| MI | 2023-08-28 | 2023-08-24 | RXST | RxSight, Inc. | Tammenoms Bakker Juliet | Dir | J - Other | $0.00 | -266.9K | 445.4K | -37% | $0 |
| 2023-08-28 | 2023-08-24 | RXST | RxSight, Inc. | Tammenoms Bakker Juliet | Dir | J - Other | $0.00 | +970 | 69.4K | +1% | $0 | |
| M | 2023-08-18 | 2023-08-17+ | RXST | RxSight, Inc. | Tammenoms Bakker Juliet | Dir | S - Sale | $29.62 | -33.1K | 83.1K | -29% | -$981.5K |
| 2023-08-11 | 2023-08-09 | RXST | RxSight, Inc. | Tammenoms Bakker Juliet | Dir | J - Other | $0.00 | +33.0K | 101.5K | +48% | $0 | |
| I | 2023-08-11 | 2023-08-09 | RXST | RxSight, Inc. | Tammenoms Bakker Juliet | Dir | J - Other | $0.00 | -497.1K | 994.3K | -33% | $0 |
| 2023-06-16 | 2023-06-14 | RXST | RxSight, Inc. | Tammenoms Bakker Juliet | Dir | J - Other | $0.00 | +1,022 | 68.6K | +2% | $0 | |
| MI | 2023-06-16 | 2023-06-14 | RXST | RxSight, Inc. | Tammenoms Bakker Juliet | Dir | J - Other | $0.00 | -266.9K | 712.7K | -27% | $0 |
| 2023-06-05 | 2023-06-01 | RXST | RxSight, Inc. | Tammenoms Bakker Juliet | Dir | A - Grant | $0.00 | +5,731 | 67.6K | +9% | $0 | |
| 2023-05-31 | 2023-05-26 | RXST | RxSight, Inc. | Tammenoms Bakker Juliet | Dir | J - Other | $0.00 | +33.1K | 61.8K | +115% | $0 | |
| I | 2023-05-31 | 2023-05-26 | RXST | RxSight, Inc. | Tammenoms Bakker Juliet | Dir | J - Other | $0.00 | -497.1K | 1.49M | -25% | $0 |
| I | 2023-02-13 | 2023-02-10 | RXST | RxSight, Inc. | Tammenoms Bakker Juliet | Dir | P - Purchase | $12.50 | +480.0K | 980.0K | +96% | +$6.00M |
| 2022-06-03 | 2022-06-02 | RXST | RxSight, Inc. | Tammenoms Bakker Juliet | Dir | A - Grant | $0.00 | +10.3K | 28.7K | +56% | $0 | |
| I | 2022-04-05 | 2022-02-10 | VERA | Vera Therapeutics, Inc. | Tammenoms Bakker Juliet | 10% | P - Purchase | $15.00 | +333.3K | 3.43M | +11% | +$5.00M |
| DMI | 2021-08-05 | 2021-08-03 | RXST | RxSight, Inc. | Tammenoms Bakker Juliet | Dir | P - Purchase | $16.00 | +625.0K | 500.0K | New | +$10.00M |
| DI | 2021-08-05 | 2021-08-03 | RXST | RxSight, Inc. | Tammenoms Bakker Juliet | Dir | C - Cnv Deriv | $0.00 | +1.86M | 1.86M | New | $0 |
| D | 2021-08-05 | 2021-08-03 | RXST | RxSight, Inc. | Tammenoms Bakker Juliet | Dir | P - Purchase | $16.00 | +12.5K | 18.4K | +213% | +$200.0K |
| 2021-08-02 | 2021-07-30 | RXST | RxSight, Inc. | Tammenoms Bakker Juliet | Dir | A - Grant | $0.00 | +5,859 | 5,859 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations